Friday, June 9, 2023
The risk for sudden cardiac death can be increased among patients with either ischemic or non-ischemic cardiomyopathies with
depressed ejection fractions who may have had a recent myocardial infarction with or without a revascularization procedure.
Arrhythmias are common and can be life-threatening; however, there are misperceptions surrounding the use of implantable cardioverter-defibrillators
(ICDs). Guidelines and reimbursement policies are not always clear, nor in agreement, as to which patients are candidates
for ICDs. The wearable cardioverter-defibrillator is an underappreciated option. Clinicians need to be aware of all patient
populations at high risk for sudden cardiac arrest, including those not meeting current treatment guidelines for ICD implantation,
so proper prevention measures may be taken in order to improve patient survival.
The educational activity presented above may involve simulated case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient is intended or should be inferred.
The material presented here does not necessarily reflect the views of Medscape, LLC, or companies that support educational programming on medscape.org. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Medscape Education© Medscape, LLC
Explore treatment options to prevent sudden cardiac death.
Explore risk stratification and optimal treatments for patients at risk for sudden cardiac death.
Drs Rao, Curtis, and Fonarow discuss risk stratification for SCD and strategies to translate the updated 2017 guidelines into
practice.
Join world expert Dr John Camm in a panel discussion focusing on patients with heart failure utilizing a WCD, an ICD, and
other treatments.
Drs Fonarow and Greenberg discuss the guidelines and recommendation for prevention of SCD/SCA in patients who have experienced
an MI.
Dr Rahul Doshi leads discussion on how to avoid sudden cardiac death in the patient after MI.
Challenge yourself to assess patients for risk of SCA/SCD at hospital discharge and learn discharge strategies to protect
at-risk patients.
Drs Varma, Barsheshet, and Kutyifa discuss the management of patients at risk of SCA, and the utility of a WCD during the
90-day period following a cardiac event.
Drs. Hauptmann, Mirro, and Garratt discuss treatment strategies based on patients’ risk of sudden cardiac arrest after PCI.
A panel of experts discuss the management of patients with newly diagnosed ischemic heart failure at risk for sudden cardiac
arrest.
Join Drs Solomon, Adamson, and Hauptman as they discuss the limitations of ICDs in patients post-MI, with HF, and at risk
for SCD.
Mortality risks after revascularization: Drs Doshi, Chung, Kandzari, and Roselli discuss who should get what, why, and when.
Drs Bhatt, Mehran, and Weintraub discuss risk stratification models as a means of identifying patients at risk for sudden
cardiac death in a post-PCI population.
Drs Stone, Hermiller, Kadish, and Rao discuss how to prevent SCA after PTCA.